Back
Speaker illustration

Mr Eduardo Pons-Fuster Lopez

Virgen de la Arrixaca University Clinical Hospital, Murcia (Spain)

Presentations

Predictive capacity of the HFA-ICOS risk stratification scale for cardiovascular adverse events in patients treated with proteasome inhibitors

Event: ESC Cardio-Oncology 2025

Topic: Stratification, Prevention and Monitoring

Session: Who is at risk of cardiovascular toxicity?

Access
Like
Thumbnail

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources